Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy.

导出 OA

翻译打印收藏纠错

第一作者： Sun Hee,Heo

第一单位： Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

作者： Sun Hee,Heo ^[1] ; Eungu,Kang ^[2] ; Yoon-Myung,Kim ^[3] ; Heounjeong,Go ^[4] ; Kyung Yong,Kim ^[5] ; Jae Yong,Jung ^[5] ; Minji,Kang ^[1] ; Gu-Hwan,Kim ^[6] ; Jae-Min,Kim ^[6] ; In-Hee,Choi ^[6] ; Jin-Ho,Choi ^[3] ; Sung-Chul,Jung ^[7] ; Robert J,Desnick ^[8] ; Han-Wook,Yoo ^[3] ; Beom Hee,Lee ^[3]

作者单位： Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ^[1] Department of Pediatrics, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea. ^[2] Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea. ^[3] Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ^[4] ISUA BXIS, Seongnam-si, Kyunggi-do, Korea. ^[5] Medical Genetics Center, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea. ^[6] Department of Biochemistry, School of Medicine, Ewha Womans University, Seoul, Korea. ^[7] Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA. ^[8]

关键词 Beta-actin Biomarker C3 Complement Fabry disease